2026-05-05T11:20:04Zhttps://uvadoc.uva.es/oai/requestoai:uvadoc.uva.es:10324/681342025-01-21T08:07:36Zcom_10324_1138com_10324_931com_10324_894col_10324_1226
Srivastava, Girish Kumar
Martínez Rodríguez, Sofía
Md Fadilah, Nur Izzah
Looi Qi Hao, Daniel
Markey, Gavin
Shukla, Priyank
Fauzi, Mh Busra
Panetsos, Fivos
2024-06-18T09:05:41Z
2024-06-18T09:05:41Z
2024
Polymers, 2024, Vol. 16, Nº. 9, 1280
2073-4360
https://uvadoc.uva.es/handle/10324/68134
10.3390/polym16091280
1280
9
Polymers
16
2073-4360
Producción Científica
Wounds are breaks in the continuity of the skin and underlying tissues, resulting from external causes such as cuts, blows, impacts, or surgical interventions. Countless individuals suffer minor to severe injuries, with unfortunate cases even leading to death. In today’s scenario, several commercial products are available to facilitate the healing process of wounds, although chronic wounds still present more challenges than acute wounds. Nevertheless, the huge demand for wound-care products within the healthcare sector has given rise to a rapidly growing market, fostering continuous research and development endeavors for innovative wound-healing solutions. Today, there are many commercially available products including those based on natural biopolymers, stem cells, and microRNAs that promote healing from wounds. This article explores the recent breakthroughs in wound-healing products that harness the potential of natural biopolymers, stem cells, and microRNAs. A comprehensive exploration is undertaken, covering not only commercially available products but also those still in the research phase. Additionally, we provide a thorough examination of the opportunities, obstacles, and regulatory considerations influencing the potential commercialization of wound-healing products across the diverse markets of Europe, America, and Asia.
Comunidad Autónoma de Madrid - (grant 82017/BMD-3760 (NEUROCENTRO-CM) and P2022/BMD-7236 (MINA-CM)
application/pdf
eng
MDPI
info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by/4.0/
© 2024 The authors
Atribución 4.0 Internacional
Dermatology
Wounds and injuries - Treatment
Heridas y lesiones - Tratamiento
Skin - Diseases
Piel - Enfermedades
Natural products
Productos naturales
Biopolymers
Biopolímeros
Stem cells
Células madre
Calidad - Control - Normas
ISO - Normas
Quality control
Medical technology
32 Ciencias Médicas
3201.06 Dermatología
3314 Tecnología Médica
Progress in wound-healing products based on natural compounds, stem cells, and microRNA-based biopolymers in the European, USA, and Asian markets: opportunities, barriers, and regulatory issues
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
https://www.mdpi.com/2073-4360/16/9/1280
SI